Literature DB >> 2109940

Effects of aging on responses of cerebral arterioles.

W G Mayhan1, F M Faraci, G L Baumbach, D D Heistad.   

Abstract

Our goal was to determine whether responses of cerebral arterioles are altered in aged rats. We examined responses of cerebral arterioles in adult (6-8 mo old) and aged (22-24) mo old) Wistar rats to superfusion of acetylcholine and bradykinin, which presumably produce dilatation by releasing an endothelium-derived relaxing factor (EDRF), and to nitroglycerin, which produces dilatation by a direct effect on vascular muscle. In adult rats, cerebral arterioles dilated by 11 +/- 2% (SE) to acetylcholine (10(-5) M) and by 21 +/- 3% to bradykinin (10(-7) M). In contrast, arterioles in aged rats dilated by only 3 +/- 1% to acetylcholine and by 7 +/- 3% to bradykinin. Vasodilatation in response to nitroglycerin was similar to adult and aged rats. We also examined responses of cerebral arterioles to products released by platelets (ADP, serotonin, and thromboxane). ADP (10(-4) M) increased pial arteriolar diameter by 26 +/- 5% in adults rats and only 12 +/- 3% in aged rats. Serotonin (10(-5) M) produced modest vasodilatation in adult rats (7 +/- 1%) but modest vasoconstriction in aged rats (-5 +/- 2%). Vasoconstriction in response to a thromboxane A2 analogue (U 46619) was similar in adult and aged rats. Indomethacin (10 mg/kg iv) did not affect responses to acetylcholine, serotonin, and ADP in aged rats. Thus dilator responses of cerebral arterioles to agonists that may release EDRF are altered in aged compared with adult rats. Impaired vasodilatation in aged rats does not appear to be related to production of a cyclooxygenase constrictor substance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109940     DOI: 10.1152/ajpheart.1990.258.4.H1138

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

Review 4.  The effect of physical exercise on endothelial function.

Authors:  Samanta Di Francescomarino; Adolfo Sciartilli; Valentina Di Valerio; Angela Di Baldassarre; Sabina Gallina
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

5.  Sustained mitochondrial functioning in cerebral arteries after transient ischemic stress in the rat: a potential target for therapies.

Authors:  Ibolya Rutkai; Prasad V G Katakam; Somhrita Dutta; David W Busija
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

6.  Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids.

Authors:  R L Matz; M A de Sotomayor; C Schott; J C Stoclet; R Andriantsitohaina
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 7.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 8.  Microvascular NADPH oxidase in health and disease.

Authors:  Yao Li; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2017-03-06       Impact factor: 7.376

9.  Up-regulation of thromboxane A₂ impairs cerebrovascular eNOS function in aging atherosclerotic mice.

Authors:  Annick Drouin; Nada Farhat; Virginie Bolduc; Nathalie Thorin-Trescases; Marc-Antoine Gillis; Louis Villeneuve; Albert Nguyen; Eric Thorin
Journal:  Pflugers Arch       Date:  2011-05-27       Impact factor: 3.657

Review 10.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.